Mara Aspinall, Founder of On-Q-ity, spoke on "Personalized Medicine and Companion Diagnostics: The Changing Biopharma Industry Landscape" at the BIO 2011 International Convention on June 30th in Washington, DC.

Mara Aspinall, CEO of On-Q-ity, participated as a panelist at the 8th Annual World Health Care Congress held from April 4-6th in Washington, DC. The panel topic was "Personalizing Medicine and Integrating Genomics into Plan Design."

Mara Aspinall, CEO of On-Q-ity, spoke at the MassBio 2011 Annual Meeting held from March 21-22th, 2011 in Cambridge, MA. Click here to watch Mara speak on MassBio and Personalized Medicine.

Mara Aspinall, CEO of On-Q-ity, presented at the Cowen and Company Healthcare Conference at 2:00 pm on March 7, 2011.

Denis Smirnov, Associate Director at On-Q-ity, spoke at the GTCbio Molecular Diagnostics Conference held over March 7-8th, 2011 in Philadelphia, PA.

Mara Aspinall, CEO of On-Q-ity, chaired a round table discussion at the "Partnering to Advance Personalized Medicine in Multiple Myeloma" event sponsored by MMRF in Boston, MA on February 10th, 2011.

Mara Aspinall, CEO of On-Q-ity, spoke at the 2011 Personalized Medicine World Conference on "The Battle for Personalized Medicine: Key Factors for Winning." PMWC 2011 was held over January 18-19th, 2011 in Silicon Valley, CA.

An interactive Case Study on Business Strategies for Personalized Medicine was presented by Richard Hamermesh, D.B.A., MBA Class of 1961 Professor of Management Practice, Harvard Business School and Mara Aspinall, CEO of On-Q-ity, on Thursday, November 18, 2010. The case "Plavix: Drugs in the Age of Personalized Medicine" will examine the development, history and outcome of this drug.

Mara Aspinall, CEO of On-Q-ity, gave a lecture as part of the Daniel C. Tosteson Series at Harvard Medical School on November 19, 2010.

Gary Palmer, CMO of On-Q-ity, spoke at the 9th International Congress on the Future of Breast Cancer held in La Jolla, CA on July 24, 2010.

Mara Aspinall, President and CEO of On-Q-ity, spoke at the 46th Annual Meeting of the Drug Information Association held in Washington D.C. from June 13-17, 2010.

Mara Aspinall, President and CEO of On-Q-ity, gave a presentation at the 2010 Medco Drug Trend Symposium in Lake Buena Vista, FL held from May 19-21, 2010.

Mara Aspinall, President and CEO of On-Q-ity, gave a presentation at the "Partnering to Advance Personalized Medicine in Multiple Myeloma" event sponsored by MMRF in Boston, MA on May 26, 2010.

Mara Aspinall, President and CEO of On-Q-ity, gave a keynote presentation, "The Future of Molecular Diagnostics", at the Molecular Diagnostics 2010 Conference in Cambridge, MA on April 15, 2010.

Brian Ward, Executive Vice President of On-Q-ity, gave a presentation, "Development of a Successful Personalized Medicine Diagnostic Test", at the Partnerships in Personalized Medicine Conference in San Mateo, CA from April 12-13, 2010.

Mara Aspinall, President and CEO of On-Q-ity, will speak during the webcast "Customizing Care: Advanced Diagnostics and the Future of Personalized Medicine" on February 3, 2010 from 12:00 - 1:30 EST. This program is the third complimentary webcast in a three-part series, Personalized Medicine: Thriving in a Rapidly Changing World, conducted by McDermott Will & Emery and Deloitte LLP.

Mara Aspinall, President and CEO of On-Q-ity, will speak at the World Health Care Congress Leadership Summit on Personalized Health Care: Optimizing Outcomes Based Data to Make Personalized Medicine a Reality. The Summit will be held in Washington D.C. on January 26, 2010.

Mara Aspinall, President and CEO of On-Q-ity, spoke at Partnering for Cures, a FasterCures meeting, in New York, NY during December 1-3, 2009.

Mara Aspinall, President and CEO of On-Q-ity, spoke at the Fifth Annual Personalized Medicine Conference, Personalized Medicine: The Time Is Now, in Boston, MA on November 18-19, 2009.

Mara Aspinall, President and CEO of On-Q-ity, spoke at the Lab Leadership Summit on November 12, 2009 in New York , NY.

Mara Aspinall, President and CEO of On-Q-ity, spoke at the Genomics and Translational Medicine Symposium at the University of Rochester, Rochester, NY on October 22-23, 2009.

Kam Sprott, PhD, Associate Director of On-Q-ity, presented a 60 min webinar on Digital Pathology Solutions for Cancer Biomarker Discovery. The webinar was broadcast at 8:00 am PST/11:00 am EST/3:00 pm GMT and 4:00 pm PST/7:00 pm EST on October 21, 2009.

Mara Aspinall, President and CEO of On-Q-ity, spoke at the Pharmacogenetics Research Network Conference in Boston, MA on October 14, 2009.

David Weaver, CSO of On-Q-ity, spoke at Pathology Visions 2009 in San Diego, CA during September 13-15, 2009.

David Weaver, CSO of On-Q-ity, spoke at the ASTRO plenary session on Translational Advances in Radiation Oncology and Cancer Imaging Symposium in St. Louis, MO on September 11, 2009.

Mara Aspinall, President and CEO of On-Q-ity, spoke at The Next Generation DX Summit in Washington, D.C. on August 12th, 2009.